In order to determine the effect of ATM on in vivo tumor growth, PRKCI-knockdown and PRKCI-overexpressing CCOC cells were intraperitoneally injected into athymic nude mice and the mice were administrated with 20 mg/kg/day for 14 consecutive days. The gene discussed is PRKCI; the disease is neoplasm.